243 related articles for article (PubMed ID: 27893290)
1. Gene alterations and epigenetic changes in intrahepatic cholangiocarcinoma.
Huang SB; Zheng CX
Expert Rev Anticancer Ther; 2017 Jan; 17(1):89-96. PubMed ID: 27893290
[TBL] [Abstract][Full Text] [Related]
2. Intrahepatic cholangiocarcinoma: current management and emerging therapies.
Rahnemai-Azar AA; Weisbrod AB; Dillhoff M; Schmidt C; Pawlik TM
Expert Rev Gastroenterol Hepatol; 2017 May; 11(5):439-449. PubMed ID: 28317403
[TBL] [Abstract][Full Text] [Related]
3. Molecular profiling of intrahepatic cholangiocarcinoma: the search for new therapeutic targets.
Oliveira DV; Zhang S; Chen X; Calvisi DF; Andersen JB
Expert Rev Gastroenterol Hepatol; 2017 Apr; 11(4):349-356. PubMed ID: 28162004
[TBL] [Abstract][Full Text] [Related]
4. Cholangiocarcinoma.
Krasinskas AM
Surg Pathol Clin; 2018 Jun; 11(2):403-429. PubMed ID: 29751883
[TBL] [Abstract][Full Text] [Related]
5. Coming of a precision era of the staging systems for intrahepatic cholangiocarcinoma?
Cheng Z; Lei Z; Shen F
Cancer Lett; 2019 Sep; 460():10-17. PubMed ID: 31212000
[TBL] [Abstract][Full Text] [Related]
6. Biomarkers of intrahepatic cholangiocarcinoma: diagnosis and response to therapy.
Brown ZJ; Hewitt DB; Pawlik TM
Front Biosci (Landmark Ed); 2022 Mar; 27(3):85. PubMed ID: 35345317
[TBL] [Abstract][Full Text] [Related]
7. Evaluation and management of intrahepatic and extrahepatic cholangiocarcinoma.
Esnaola NF; Meyer JE; Karachristos A; Maranki JL; Camp ER; Denlinger CS
Cancer; 2016 May; 122(9):1349-69. PubMed ID: 26799932
[TBL] [Abstract][Full Text] [Related]
8. [Recent progress in molecular targeted therapies for intrahepatic cholangiocarcinoma].
Xie ZH; Li J; Xia Y; Shen F
Zhonghua Wai Ke Za Zhi; 2020 Apr; 58(4):289-294. PubMed ID: 32241059
[TBL] [Abstract][Full Text] [Related]
9. Current approaches to the diagnosis and treatment of cholangiocarcinoma.
Reddy SB; Patel T
Curr Gastroenterol Rep; 2006 Feb; 8(1):30-7. PubMed ID: 16510032
[TBL] [Abstract][Full Text] [Related]
10. EYA4 gene functions as a prognostic marker and inhibits the growth of intrahepatic cholangiocarcinoma.
Hao XY; Cai JP; Liu X; Chen W; Hou X; Chen D; Lai JM; Liang LJ; Yin XY
Chin J Cancer; 2016 Jul; 35(1):70. PubMed ID: 27469137
[TBL] [Abstract][Full Text] [Related]
11. Intrahepatic cholangiocarcinoma.
Poultsides GA; Zhu AX; Choti MA; Pawlik TM
Surg Clin North Am; 2010 Aug; 90(4):817-37. PubMed ID: 20637950
[TBL] [Abstract][Full Text] [Related]
12. New routes to targeted therapy of intrahepatic cholangiocarcinomas revealed by next-generation sequencing.
Ross JS; Wang K; Gay L; Al-Rohil R; Rand JV; Jones DM; Lee HJ; Sheehan CE; Otto GA; Palmer G; Yelensky R; Lipson D; Morosini D; Hawryluk M; Catenacci DV; Miller VA; Churi C; Ali S; Stephens PJ
Oncologist; 2014 Mar; 19(3):235-42. PubMed ID: 24563076
[TBL] [Abstract][Full Text] [Related]
13. Molecular profiling of intrahepatic and extrahepatic cholangiocarcinoma using next generation sequencing.
Putra J; de Abreu FB; Peterson JD; Pipas JM; Mody K; Amos CI; Tsongalis GJ; Suriawinata AA
Exp Mol Pathol; 2015 Oct; 99(2):240-4. PubMed ID: 26189129
[TBL] [Abstract][Full Text] [Related]
14. Current challenges to underpinning the genetic basis for cholangiocarcinoma.
Cigliano A; Chen X; Calvisi DF
Expert Rev Gastroenterol Hepatol; 2021 May; 15(5):511-526. PubMed ID: 33888034
[TBL] [Abstract][Full Text] [Related]
15. A review of the clinical diagnosis and therapy of cholangiocarcinoma.
Yao D; Kunam VK; Li X
J Int Med Res; 2014 Feb; 42(1):3-16. PubMed ID: 24366497
[TBL] [Abstract][Full Text] [Related]
16. Genetic and epigenetic changes associated with cholangiocarcinoma: from DNA methylation to microRNAs.
Stutes M; Tran S; DeMorrow S
World J Gastroenterol; 2007 Dec; 13(48):6465-9. PubMed ID: 18161915
[TBL] [Abstract][Full Text] [Related]
17. Identification of a novel microRNA signature associated with intrahepatic cholangiocarcinoma (ICC) patient prognosis.
Zhang MY; Li SH; Huang GL; Lin GH; Shuang ZY; Lao XM; Xu L; Lin XJ; Wang HY; Li SP
BMC Cancer; 2015 Feb; 15():64. PubMed ID: 25880914
[TBL] [Abstract][Full Text] [Related]
18. Systemic treatment of advanced or recurrent biliary tract cancer.
Zhang W; Zhou H; Wang Y; Zhang Z; Cao G; Song T; Zhang T; Li Q
Biosci Trends; 2020 Nov; 14(5):328-341. PubMed ID: 32830166
[TBL] [Abstract][Full Text] [Related]
19. Staging, prognostic factors and adjuvant therapy of intrahepatic cholangiocarcinoma after curative resection.
Li T; Qin LX; Zhou J; Sun HC; Qiu SJ; Ye QH; Wang L; Tang ZY; Fan J
Liver Int; 2014 Jul; 34(6):953-60. PubMed ID: 24134199
[TBL] [Abstract][Full Text] [Related]
20. Advances in the Diagnosis and Treatment of Patients with Intrahepatic Cholangiocarcinoma.
Ejaz A; Cloyd JM; Pawlik TM
Ann Surg Oncol; 2020 Feb; 27(2):552-560. PubMed ID: 31555936
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
